Higher serum concentration of overlapping metabolites was observed in MS patients during spring and fall [55] and a significant increase in pro-inflammatory cytokine production (such as Il-6, TNF-alfa, and IFN-gamma) was seen from spring to summer. The gene discussed is IFNG; the disease is myeloid sarcoma.